Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-08-16
2011-08-16
Bowman, Amy (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024500
Reexamination Certificate
active
07998939
ABSTRACT:
The invention provides aptamers capable of binding to thrombin useful as therapeutics for and diagnostics of coagulation related disorders and/or other diseases or disorders in which thrombin has been implicated. The invention further provides materials and methods for the administration of aptamers capable of binding to thrombin.
REFERENCES:
patent: 5756291 (1998-05-01), Griffin et al.
patent: 6056715 (2000-05-01), Demopulos et al.
patent: 2003/0054360 (2003-03-01), Gold et al.
patent: 2004/0197804 (2004-10-01), Keefe et al.
patent: 2006/0057573 (2006-03-01), Gold et al.
patent: WO 92/14842 (1992-09-01), None
patent: WO 9214842 (1992-09-01), None
patent: WO 2003/070984 (2003-08-01), None
patent: WO 2005/010150 (2005-02-01), None
patent: WO 2007/036016 (2007-04-01), None
patent: WO 2007/044851 (2007-04-01), None
Fitter, et al., “Deconvolution of a Complex Target Using DNA Aptamers,”J Biol Chem280(40):34193-34201 (2005).
Bock et al., “Selection of single-stranded DNA molecules that bind and inhibit human thrombin,”Nature, 355(6360):564-566, 1992.
Burmeister et al., “2'-deoxy purine, 2'-0-methyl pyrimidine (dRmY) aptamers as candidate therapeutics,”Oligonucleotides, 16(4):337-351, 2006.
Di Giusto et al., “Construction, stability, and activity of multivalent circular anticoagulant aptamers,”Journal of Biological Chemistry, 279(45):46483-46489, 2004.
Griffin et al., “The discovery and characterization of a novel nucleotide-based thrombin inhibitor,”Gene, 137(1):25-31, 1993.
Office Communication, issued in European Patent Application No. 06813718.1, dated Sep. 28, 2010.
Smirnov et al., “Effect of loop sequence and size on DNA aptamer stability,”Biochemistry, 39(1):1462-1468, 2000.
Tasset et al., “Oligonucleotide inhibitors of human thrombin that bind distinct epitopes,”Journal of Molecular Biology, 272(5):688-698, 1997.
Diener John L.
Fontana David
Wagner-Whyte Jess
Archemix Corporation
Bowman Amy
Fulbright & Jaworski L.L.P.
LandOfFree
Aptamers that bind thrombin with high affinity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aptamers that bind thrombin with high affinity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aptamers that bind thrombin with high affinity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2688564